ProPhase Labs Inc

NASDAQ:PRPH USA Diagnostics & Research
Market Cap
$426.33K
Market Cap Rank
#37964 Global
#12363 in USA
Share Price
$0.09
Change (1 day)
-28.00%
52-Week Range
$0.09 - $0.97
All Time High
$14.70
About

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart … Read more

ProPhase Labs Inc (PRPH) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -3.137x

Based on the latest financial reports, ProPhase Labs Inc (PRPH) has a cash flow conversion efficiency ratio of -3.137x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-21.52 Million) by net assets ($6.86 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

ProPhase Labs Inc - Cash Flow Conversion Efficiency Trend (1996–2024)

This chart illustrates how ProPhase Labs Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

ProPhase Labs Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ProPhase Labs Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for ProPhase Labs Inc (1996–2024)

The table below shows the annual cash flow conversion efficiency of ProPhase Labs Inc from 1996 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $7.35 Million $-17.54 Million -2.385x -937.94%
2023-12-31 $49.38 Million $-11.35 Million -0.230x -151.21%
2022-12-31 $63.63 Million $28.55 Million 0.449x +293.16%
2021-12-31 $58.63 Million $-13.62 Million -0.232x +5.40%
2020-12-31 $10.56 Million $-2.59 Million -0.246x -227.91%
2019-12-31 $11.23 Million $-841.00K -0.075x +41.68%
2018-12-31 $16.50 Million $-2.12 Million -0.128x -49.70%
2017-12-31 $33.09 Million $-2.84 Million -0.086x -8.34%
2016-12-31 $5.96 Million $-472.00K -0.079x +80.01%
2015-12-31 $8.83 Million $-3.50 Million -0.396x -31.98%
2014-12-31 $10.72 Million $-3.22 Million -0.300x -432.47%
2013-12-31 $12.60 Million $1.14 Million 0.090x +118.04%
2012-12-31 $11.45 Million $-5.73 Million -0.500x -166.43%
2011-12-31 $11.23 Million $-2.11 Million -0.188x +28.78%
2010-12-31 $13.46 Million $-3.55 Million -0.264x -933.02%
2009-12-31 $14.06 Million $445.00K 0.032x +118.40%
2008-12-31 $17.77 Million $-3.06 Million -0.172x -205.56%
2007-12-31 $23.30 Million $-1.31 Million -0.056x -250.57%
2006-12-31 $25.59 Million $956.94K 0.037x -77.76%
2005-12-31 $25.37 Million $4.27 Million 0.168x -20.79%
2004-12-31 $21.96 Million $4.66 Million 0.212x +556.59%
2003-12-31 $20.79 Million $-966.23K -0.046x -257.52%
2002-12-31 $18.42 Million $543.64K 0.030x +156.01%
2001-12-31 $21.20 Million $-1.12 Million -0.053x +40.24%
2000-12-31 $21.21 Million $-1.87 Million -0.088x -277.69%
1999-12-31 $26.20 Million $1.30 Million 0.050x -75.14%
1998-12-31 $44.60 Million $8.90 Million 0.200x -7.54%
1997-12-31 $41.70 Million $9.00 Million 0.216x +123.54%
1996-12-31 $1.20 Million $-1.10 Million -0.917x --